Összefoglaló. Kilenc magyarországi orvostársaság közös ajánlást alakított ki a D-vitamin javasolt normáltartományával, a D-vitamin-pótlás adagjával és az adagolás módjával kapcsolatban. Összefoglalták azokat a klinikai állapotokat, betegségeket, amelyek kialakulása összefüggésben lehet a D-vitamin-hiánnyal. Magyarországon a D-vitamin-hiány – főleg a tél végére – rendkívül gyakori. A javasolt normáltartomány alsó határa 75 nmol/l, annak ellenére, hogy a hiány klinikai jelentősége főleg 50 nmol/l alatti értékeknél nyilvánvaló, ám mivel a D-vitamin pótlása a javasolt dózisban biztonságos, mindenkinél érdemes csökkenteni a D-vitamin-hiánnyal kapcsolatos egészségügyi kockázatot. A D-vitamin-pótlás célja a hiány megszüntetése. A javasolt normáltartomány 75–125 nmol/l, az ezt meghaladó tartományban a D-vitamin adásának nincs további egyértelmű előnye. A normáltartomány fenntartásához felnőttekben napi 2000 NE bevitele javasolt az UV-B sugárzástól mentes időszakban. Gyermekeknek is javasolt a D-vitamin pótlása azokban az időszakokban és állapotokban, mint a felnőtteknek, de az adag korfüggő módon változik. D-vitamin-pótlásra D3-vitamin adása javasolt. Felnőttekben a D3-vitamin-pótlás napi, heti és havi gyakoriságú adagolással is egyformán hatásos és biztonságos. Súlyos hiányban javasolt telítő adagot alkalmazni, majd ezt követően fenntartó adagolással kell folytatni a pótlást. A D-vitamin-hiány jól ismert csontrendszeri, immunológiai és onkológiai hatásai mellett egyre több adat támasztja alá előnytelen nőgyógyászati és szülészeti hatásait is. A legerősebb érv a D-vitamin-hiány megszüntetése és a szükséges pótlás alkalmazása mellett a halálozási kockázat D-vitamin-hiányban észlelt növekedése. A konszenzus elkészítésének folyamata megfelelt a Delfi-irányelveknek. Orv Hetil. 2022; 163(15): 575–584.
Summary. Nine Hungarian medical societies have developed a consensus recommendation on the preferred normal range of vitamin D, the dose of vitamin D supplementation and the method of administration. They summarized the clinical conditions and diseases the development of which may be associated with vitamin D deficiency (VDD). VDD is extremely common in Hungary, especially in late winter. The lower limit of the recommended normal range is 75 nmol/l, although the clinical significance of deficiency is evident mainly at values below 50 nmol/l, but since vitamin D supplementation at the recommended dose is safe, it is worthwhile for everyone to reduce the health risk associated with VDD. The aim of vitamin D supplementation is to prevent deficiency. The recommended normal range is 75–125 nmol/l, above which there is no clear benefit of vitamin D supplementation. To maintain the normal range, a daily intake of 2000 IU in adults is recommended during the UV-B radiation-free period. Vitamin D supplementation is also recommended for children during the same periods and conditions as for adults, but the dose varies with age. In adults, vitamin D3 supplementation at daily, weekly and monthly intervals is equally effective and safe. In severe deficiency, a loading dose is recommended, followed by maintenance supplementation. In addition to the well-known skeletal, immunological and oncological effects of VDD, more and more data support unfavorable gynecological and obstetric effects. The process of building the consensus has met the requirements of the latest Delphi criteria. Orv Hetil. 2022; 163(15): 575–584.
Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014; 67: 401–409.
Holick MF, Chen TC, Lu Z, et al. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res. 2007; 22(Suppl 2): V28–V33.
Need AG, Morris HA, Horowitz M, et al. Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr. 1993; 58: 882–885.
Szabó B, Tabák ÁG, Toldy E, et al. The role of serum total and free 25-hydroxyvitamin D and PTH values in defining vitamin D status at the end of winter: a representative survey. J Bone Miner Metab. 2017; 35: 83–90.
Zajkás G, Bíró L, Greiner E, et al. Dietary survey in Hungary, 2003–2004. Micronutrients: vitamins. [Táplálkozási vizsgálat Magyarországon, 2003–2004. Mikrotápanyagok: vitaminok.] Orv Hetil. 2007; 148: 1593–1600. [Hungarian]
Eelen G, Verlinden L, van Camp M, et al. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. J Bone Miner Res. 2004; 19: 133–146.
Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010; 25: 305–312.
Manson JE, Cook NR, Lee IM, et al.; VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019; 380: 33–44.
Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019; 381: 520–530.
Takács I, Tóth BE, Szekeres L, et al. Randomized clinical trial to comparing efficacy of daily, weekly and monthly administration of vitamin D3. Endocrine 2017; 55: 60–65.
Blank S, Scanlon KS, Sinks TH, et al. An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. Am J Public Health 1995; 85: 656–659.
Vieth R, Kimball S, Hu A, et al. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004; 3: 8.
Zittermann A, Ernst JB, Prokop S, et al. Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily. Eur Heart J. 2017; 38: 2279–2286.
Amir E, Simmons CE, Freedman OC, et al. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases. Cancer 2010; 116: 284–291.
Seitz S, Koehne T, Ries C, et al. Impaired bone mineralization accompanied by low vitamin D and secondary hyperparathyroidism in patients with femoral neck fracture. Osteoporosis Int. 2013; 24: 641–649.
Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815–1822.
Reid IR, Bolland MJ. Controversies in medicine: the role of calcium and vitamin D supplements in adults. Med J Aust. 2019; 211: 468–473.
Yao P, Bennett D, Mafham M, et al. Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis. JAMA Netw Open 2019; 2: e1917789.
Adami S, Isaia G, Luisetto G, et al. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res. 2006; 21: 1565–1570.
Rolighed L, Rejnmark L, Sikjaer T, et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab. 2014; 99: 1072–1080.
Bilezikian JP, Bikle D, Hewison M, et al. Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol. 2020; 183: R133–R147.
Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003; 170: 5382–5390.
Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6: 231–243.
Jiménez-Sousa MÁ, Martínez I, Medrano LM, et al. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol. 2018; 9: 458.
Lucas RM, Gorman S, Geldenhuys S, et al. Vitamin D and immunity. F1000Prime Rep. 2014; 6: 118.
Pozzilli P, Manfrini S, Crinò A, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005; 37: 680–683.
Cutolo M, Otsa K, Paolino S, et al. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis. 2009; 68: 446–447.
Kerr GS, Sabahi I, Richards JS, et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol. 2011; 38: 53–59.
Hassanalilou T, Khalili L, Ghavamzadeh S, et al. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation. Auto Immun Highlights 2017; 9: 1.
Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29: 726–776.
Ma Y, Zhang P, Wang F, et al. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol. 2011; 29: 3775–3782.
Zhou L, Chen B, Sheng L, et al. The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis. Breast Cancer Res Treat. 2020; 182: 1–8.
Keum N, Lee DH, Greenwood DC, et al. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019; 30: 733–743.
Hossain S, Beydoun MA, Beydoun HA, et al. Vitamin D and breast cancer: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 2019; 30: 170–184.
Estébanez N, Gómez-Acebo I, Palazuelos C, et al. Vitamin D exposure and risk of breast cancer: a meta-analysis. Sci Rep. 2018; 8: 9039.
Yin L, Grandi N, Raum E, et al. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009; 30: 113–125.
Huang D, Lei S, Wu Y, et al. Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: a systematic review and meta-analysis. Clin Nutr. 2020; 39: 2525–2538.
Shahvazi S, Soltani S, Ahmadi SM, et al. The effect of vitamin D supplementation on prostate cancer: a systematic review and meta-analysis of clinical trials. Horm Metab Res. 2019; 51: 11–21.
Stroomberg HV, Vojdeman FJ, Madsen CM, et al. Vitamin D levels and the risk of prostate cancer and prostate cancer mortality. Acta Oncol. 2021; 60: 316–322.
Dennis NA, Houghton LA, Jones GT, et al. The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab. 2012; 97: 2450–2455.
Hughes MM, Katz J, Mullany LC, et al. Seasonality of birth outcomes in rural Sarlahi District, Nepal: a population-based prospective cohort. BMC Pregnancy Childbirth 2014; 14: 310.
Iliuta F, Pijoan JI, Lainz L, et al. Women’s vitamin D levels and IVF results: a systematic review of the literature and meta-analysis, considering three categories of vitamin status (replete, insufficient and deficient). Hum Fertil (Camb). 2020; Aug 14. 1–19. . [Epub ahead of print]
Lee CL, Ng BK, Wu LL, et al. Vitamin D deficiency in pregnancy at term: risk factors and pregnancy outcomes. Horm Mol Biol Clin Investig. 2017; 31(3). .
Bodnar LM, Catov JM, Simhan HN, et al. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007; 92: 3517–3522.
Merewood A, Mehta SD, Chen TC, et al. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab. 2009; 94: 940–945.
Jefferson KK, Parikh HI, Garcia EM, et al. Relationship between vitamin D status and the vaginal microbiome during pregnancy. J Perinatol. 2019; 39: 824–836.
Hatun S, Ozkan B, Orbak Z, et al. Vitamin D deficiency in early infancy. J Nutr. 2005; 135: 279–282.
Uçar N, Grant WB, Peraita-Costa I, et al. How 25(OH)D levels during pregnancy affect prevalence of autism in children: systematic review. Nutrients 2020; 12: 2311.
Pal L, Zhang HP, Williams J, et al. Vitamin D status relates to reproductive outcome in women with polycystic ovary syndrome: secondary analysis of a multicenter randomized controlled trial. J Clin Endocr Metab. 2016; 101: 3027–3035.
Menichini D, Forte G, Orrù B, et al. The role of vitamin D in metabolic and reproductive disturbances of polycystic ovary syndrome: a narrative mini-review. Int J Vitam Nutr Res. 2020 Dec 7. 1–8. . [Epub ahead of print]
Riazi H, Ghazanfarpour M, Taebi M, et al. Effect of vitamin D on the vaginal health of menopausal women: a systematic review. J Menopausal Med. 2019; 25: 109–116.
Giulietti A, Gysemans C, Stoffels K, et al. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 2004; 47: 451–462.
Hyppönen E, Läärä E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500–1503.
Zhang Y, Tan H, Tang J, et al. Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: a systematic review and meta-analysis. Diabetes Care 2020; 43: 1650–1658.
Li X, Liu Y, Zheng Y, et al. The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients 2018; 10: 375.
Bellan M, Andreoli L, Mele C, et al. Pathophysiological role and therapeutic implications of vitamin D in autoimmunity: focus on chronic autoimmune diseases. Nutrients 2020; 12: 789.
Xu MY, Cao B, Yin J, et al. Vitamin D and Graves’ disease: a meta-analysis update. Nutrients 2015; 7: 3813–3827.
Cardoso MP, Pereira LA. Native vitamin D in pre-dialysis chronic kidney disease. Nefrologia (Engl ed.) 2019; 39: 18–28.
Strugnell SA, Sprague SM, Ashfaq A, et al. Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease. Am J Nephrol. 2019; 49: 284–293.
Melamed ML, Chonchol M, Gutiérrez OM, et al. The role of vitamin D in CKD stages 3 to 4: report of a scientific workshop sponsored by the National Kidney Foundation. Am J Kidney Dis. 2018; 72: 834–845.
Kandula P, Dobre M, Schold JD, et al. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011; 6: 50–62.
Agarwal R, Georgianos PI. Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease. Nephrol Dial Transpl. 2016; 31: 706–713. [Erratum: Nephrol Dial Transpl. 2021; 36: 566–567.]
Tangpricha V, Wasse H. Vitamin D therapy in kidney disease: more vitamin D is necessary. Am J Kidney Dis. 2014; 64: 667–669.
Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020; 76(3 Suppl 1): S1–S107. [Erratum: Am J Kidney Dis. 2021; 77: 308.]